University of Calgary: Heart Failure trials

The registry lists 13 Heart Failure studies with University of Calgary as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 3Phase 4 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Information System Impact on Hospitalized Patients With Chronic DiseaseNot yet recruitingNCT07609381
• Assessing Systemic Circulation and LV Performance in AdultsRecruitingNCT04347655Not applicable
• ENCOMPASS: Expansion Study CCompletedNCT04791267Not applicable
• ENCOMPASS: Expansion Study B, RCTCompletedNCT04790617Not applicable
• ENCOMPASS: Expansion Study A, RCTCompletedNCT04790604Not applicable
• Sildenafil for the Prevention of Right Heart Failure Following LVAD ImplantationStatus unknownNCT03356353Phase 3
• Enhancing Community Health Through Patient Navigation, Advocacy and Social SupportCompletedNCT03077386Not applicable
• Tolvaptan for Advanced or Refractory Heart FailureTerminatedNCT02959411Phase 4
• Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary StudyCompletedNCT02579655Not applicable
• Torsion Optimization to Reduce Symptoms and Improve Outcomes in Non-respondersStatus unknownNCT00867984Phase 3
• Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy.CompletedNCT00489177Phase 4
• Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.CompletedNCT00399594Phase 2/3
• Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood PressureCompletedNCT00115726Phase 4